Literature DB >> 19779775

Superior vena cava reconstruction via a posterolateral thoracotomy without venous occlusion for locally advanced lung cancer: report of a case.

Hirohiko Shinohara1, Masanori Tsuchida, Takehisa Hashimoto, Seijirou Satoh, Ai Takeuchi, Mariko Takeshige, Jun-ichi Hayashi.   

Abstract

We performed a right upper lobectomy with prosthetic replacement of the superior vena cava (SVC) through a posterolateral thoracotomy in a 65-year-old man undergoing complete resection of a locally advanced non-small-cell lung cancer with invasion of the SVC. Instead of using a vascular shunt, the right atrium and a right brachiocephalic vein (BCV) were anastomosed using a ringed polytetrafluoroethylene (PTFE) graft. During the anastomosis, vascular flow was maintained through the left BCV. By using this technique, SVC resection and reconstruction during lung cancer surgery can be safely performed through a posterolateral thoracotomy without blood flow interruption.

Entities:  

Mesh:

Year:  2009        PMID: 19779775     DOI: 10.1007/s00595-008-3927-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

1.  Is lung cancer surgery justified in patients with direct mediastinal invasion?

Authors:  C Doddoli; G Rollet; P Thomas; O Ghez; Y Serée; R Giudicelli; P Fuentes
Journal:  Eur J Cardiothorac Surg       Date:  2001-08       Impact factor: 4.191

2.  Hemodynamic instability during superior vena cava crossclamping: predictors, management, and clinical consequences.

Authors:  Francesco Leo; Laura Della Grazia; Marco Tullii; Roberto Gasparri; Alessandro Borri; Marco Venturino; Lorenzo Spaggiari
Journal:  J Thorac Cardiovasc Surg       Date:  2007-04       Impact factor: 5.209

Review 3.  Impact of smoking status on the biological behavior of lung cancer.

Authors:  Ichiro Yoshino; Yoshihiko Maehara
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

4.  Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases.

Authors:  Lorenzo Spaggiari; Francesco Leo; Giulia Veronesi; Piergiorgio Solli; Domenico Galetta; Brunilda Tatani; Francesco Petrella; Davide Radice
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

5.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.

Authors:  K Furuse; M Fukuoka; M Kawahara; H Nishikawa; Y Takada; S Kudoh; N Katagami; Y Ariyoshi
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

6.  Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.

Authors:  Kathy S Albain; John J Crowley; Andrew T Turrisi; David R Gandara; William B Farrar; Joseph I Clark; Kristie R Beasley; Robert B Livingston
Journal:  J Clin Oncol       Date:  2002-08-15       Impact factor: 44.544

7.  Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion.

Authors:  Kenji Suzuki; Hisao Asamura; Shun-ichi Watanabe; Ryosuke Tsuchiya
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

  7 in total
  1 in total

Review 1.  Extended pneumonectomy for advanced lung cancer with cardiovascular structural invasions.

Authors:  Shi-Min Yuan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.